Core Viewpoint - Aixin Yuan Zhi has passed the main board listing hearing on the Hong Kong Stock Exchange, with CICC, Guotai Junan, and Bank of Communications International as joint sponsors [1] Company Overview - Aixin Yuan Zhi is a fabless supplier of artificial intelligence inference system-on-chip (SoC), focusing on high-performance perception and computing platforms for edge computing and terminal device AI applications [1] - The company's core technologies include the Axera Neutron mixed-precision neural network processor (NPU) and the Axera Proton AI-ISP, which is the world's first commercially scaled AI image signal processor [1] Market Position - According to Zhi Zhi Consulting, Aixin Yuan Zhi is the largest supplier of mid-to-high-end visual edge AI inference chips globally by shipment volume in 2024, ranking among the top five in the global visual edge AI inference chip market [1] Product Development and Sales - As of September 30, 2025, Aixin Yuan Zhi has independently developed and commercialized five generations of SoCs, with cumulative deliveries exceeding 165 million units [1] - In 2024, the company's AI inference SoC shipments reached 9.3 million units, with sales of visual terminal computing SoCs and edge computing SoCs increasing by approximately 69% and 400% respectively compared to 2023 [1]

二 〇 二 六 年 度 2026 年 1 月 25 日 生猪：旺季需求预期将落地，供应矛盾显现 | 周小球 | 投资咨询从业资格号：Z0001891 | zhouxiaoqiu@gtht.com | | --- | --- | --- | | 吴昊 | 投资咨询从业资格号：Z0018592 | wuhao8@gtht.com | 报告导读： （1）本周市场回顾（1.19-1.25） 现货市场，生猪价格震荡调整。河南 20KG 仔猪价格 27.35 元/公斤（上周 25.3 元/公斤），本周河南 生猪价格 13.28 元/公斤（上周 13.18 元/公斤），全国 50KG 二元母猪价格 1559 元/头（上周 1559 元/ 头）。供应端，集团企业恢复计划出栏量，南北方散户仍有惜售情绪，出栏意愿增量；需求端，下游屠宰 旺季亏损，宰量整体下降。根据卓创资讯数据，本周全国出栏平均体重 124.5KG（上周 124.58KG），出栏 均重环比下降 0.06%。 期货市场，生猪期货价格弱势运行。本周生猪期货 LH2603 合约最高价为 12140 元/吨，最低价为 11400 元/吨，收盘价为 11565 元/吨（上周 ...

国泰君安期货·有色及贵金属 周报合集 国泰君安期货研究所·有色及贵金属团队 王 蓉 投资咨询从业资格号：Z0002529 wangrong2@gtht.com 季先飞 投资咨询从业资格号：Z0012691 jixianfei@gtht.com 刘雨萱 投资咨询从业资格号：Z0020476 liuyuxuan@gtht.com 王宗源 （联系人）从业资格号：F03142619 wangzongyuan@gtht.com 2026年01月25日 Guotai Junan Futures all rights reserved, please do not reprint 1 06 铅：缺乏驱动，价格震荡 07 锡周报 铂金：交易重心成功上移，钯金：跟随上涨 Special report on Guotai Junan Futures 2 2 CONTENTS 01 黄金：上调目标位至5500 白银：关注整数位压力 02 03 铜：美元回落和长期基本面向好，支撑价格持续偏强 铝：高位震荡，边际仍有偏向上动能 氧化铝：底部小盘整，仍持续持有高位空思路 04 铸造铝合金：价格高位震荡，下游逢低补库 05 锌：供应偏弱， ...

Investment Rating - The industry investment rating is "Buy" [3] Core Insights - The report highlights a significant increase in insurance holdings, with public fund holdings in the non-bank financial sector rising from 1.49% in Q3 2025 to 2.48% in Q4 2025, driven by market style rebalancing and marginal support from the sector's fundamentals [24][34] - The report notes that despite the ongoing pursuit of high-elasticity technology sectors, the non-bank financial sector is at a historical low valuation, with strong performance in the insurance sector and increased trading volumes in brokerage firms, indicating fundamental resilience [24][34] - The report suggests that the public fund holdings in the securities sector increased slightly from 0.63% in Q3 2025 to 0.71% in Q4 2025, reflecting improved performance trends and the appeal of low valuations [33] Summary by Sections New Public Fund Issuance - In Q4 2025, the number of newly issued funds remained stable at approximately 477, with a year-on-year increase of 81% compared to 264 in Q4 2024, while the issuance volume decreased by 15.19% year-on-year [12][19] - The share of newly issued equity funds decreased from 41% in the previous quarter to 32%, while mixed fund shares increased from 15% to 19% [12] Non-Bank Financial Fund Holdings - Public fund holdings in the non-bank financial sector increased, with the total market capitalization share rising to 2.48% in Q4 2025 [24] - The report attributes this increase to a shift in funds from crowded technology sectors to undervalued defensive sectors, alongside a recovery in northbound capital allocations [24] Major Non-Bank Companies' Holdings - The report indicates that major non-bank companies saw slight increases in public fund holdings, with China Ping An leading at 1.11% and China Pacific Insurance at 0.35% [41] - The report recommends focusing on key companies such as CITIC Securities, Huatai Securities, and China Ping An for potential investment opportunities [24][41]

Core Insights - The report highlights that the short-term changes in broad-based ETF shares are impacting weighted stocks, while long-term regulatory changes are constraining deviations in benchmarks [1][5]. Group 1: Market Performance - As of January 24, 2026, the Shanghai Composite Index rose by 0.84%, while the Shenzhen Component Index increased by 1.11%. The CSI 300 Index fell by 0.62%, and the ChiNext Index decreased by 0.34% [10]. - The average daily trading volume in the Shanghai and Shenzhen markets was 2.80 trillion yuan, reflecting a 19% decrease compared to the previous period [5]. Group 2: Industry Dynamics and Weekly Commentary Insurance Sector - The performance of listed insurance companies is expected to continue high growth, with marginal improvements in long-term interest spreads. The 10-year government bond yield was 1.83%, down 1 basis point from the previous week, indicating a stable economic outlook [11][14]. - The insurance sector is benefiting from regulatory changes that enhance asset-liability management capabilities, which are expected to support high growth in 2026. Key stocks to watch include China Ping An, China Life, and New China Life [14][15]. Securities Sector - The report notes a significant decline in broad-based ETF shares, with the CSI 1000 dropping by 42%, the SSE 50 by 25%, and the CSI 300 by 23%. This decline is expected to have a direct impact on the trading volumes of associated leading stocks [15][19]. - The China Securities Regulatory Commission has introduced new guidelines for public fund performance benchmarks, effective March 1, 2026, aimed at enhancing stability and protecting investor interests [24][28]. Group 3: Key Company Valuations and Financial Analysis - China Ping An (601318.SH) has a current price of 68.40 CNY, with a target value of 85.17 CNY, indicating a buy rating. The expected EPS for 2025 is 8.91 CNY, with a PE ratio of 7.68x [6]. - New China Life (601336.SH) is rated as a buy with a target value of 94.21 CNY, and an expected EPS of 14.04 CNY for 2025, reflecting a PE ratio of 4.96x [6]. - China Pacific Insurance (601601.SH) is also rated as a buy, with a target value of 52.44 CNY and an expected EPS of 6.09 CNY for 2025, resulting in a PE ratio of 6.88x [6].

Core Viewpoint - The Guotai Haitong Consumption Opportunity Mixed Fund A (019433) reported a profit of 78,600 yuan in Q4 2025, with a weighted average profit per fund share of 0.0097 yuan. The fund's net value growth rate for the reporting period was 0.93%, and the fund size reached 8.61 million yuan by the end of Q4 2025 [3][17]. Fund Performance - As of January 22, the fund's unit net value was 1.06 yuan. The fund manager, Fan Yang, oversees four funds, all of which have positive returns over the past year. The highest one-year cumulative net value growth rate among these funds was 54.86% for Guotai Haitong Jun Dexin 2-Year Holding Mixed A, while the lowest was 7.78% for Guotai Haitong Consumption Opportunity Mixed Fund A [3]. - The fund's performance over different time frames includes a three-month net value growth rate of 2.81%, a six-month growth rate of 7.54%, and a one-year growth rate of 7.78%, ranking 15th out of 85, 14th out of 85, and 44th out of 83 among comparable funds, respectively [4]. Risk and Return Metrics - The fund has a Sharpe ratio of 0.3595 since inception, indicating a moderate level of risk-adjusted return [9]. - The maximum drawdown since inception is 22.31%, with the largest quarterly drawdown occurring in Q3 2024 at 14.32% [13]. Investment Strategy - The fund maintains a high average stock position of 85.98% since inception, with a peak of 92.07% at the end of 2025 and a low of 70.31% at the end of 2024 [16]. - The fund's portfolio is highly concentrated, with the top ten holdings including Sailun Tire, Hisense Visual Technology, Senki Lin, Muyuan Foods, Tiankang Biology, Great Wall Motors, Stone Technology, Youran Agriculture, Baiya Shares, and Xingyu Shares [20]. Future Outlook - The fund management anticipates continued investment in service consumption, focusing on new consumption led by younger demographics and elder consumption driven by the aging population. They aim to achieve better investment returns by leveraging structural changes in consumer demographics and validating corporate competitiveness amid trade tensions [3].

Core Viewpoint - The non-bank financial sector is underweight, with a total underweight of 3.08 percentage points, despite an increase in holdings in the fourth quarter, indicating potential investment opportunities as resident funds enter the market under a low interest rate environment [1][4]. Group 1: Brokerage Sector - The brokerage sector has received an increase in allocation, with public funds (excluding passive index funds) raising their holding ratio from 0.85% to 1.08%, still underweight by 2.30 percentage points [2]. - The Wind All A Index rose by 0.97% in the fourth quarter, with a quarterly stock fund transaction volume of 24.5 trillion, indicating active market trading that has led to increased fund allocation to the brokerage sector [2]. - Notable individual stock increases include Citic Securities' holding ratio rising from 0.1687% to 0.3132% and Huatai Securities' from 0.1579% to 0.1989% [2]. Group 2: Insurance Sector - The allocation ratio for the insurance sector significantly increased from 1.03% to 2.13%, with an underweight of 0.33%, and the insurance index rose by 23.42% in the fourth quarter [3]. - Individual stock increases include China Life's holding ratio rising from 0.019% to 0.020%, Ping An's from 0.68% to 1.449%, and China Pacific Insurance's from 0.22% to 0.422% [3]. - The expectation of continued capital inflow and a focus on undervalued targets supports the recommendation for insurance stocks [3]. Group 3: Multi-Financial and Fintech Sectors - The allocation ratio for the multi-financial and fintech sectors decreased from 0.204% to 0.145% [3]. - Individual stocks such as Lakala and Yuexiu Financial Holdings received increased allocations, with holding ratios rising from 0% to 0.0027% and 0% to 0.0025%, respectively [3]. - The outlook remains positive for financial information services, third-party payments, and equity investment opportunities due to ongoing policy support for capital inflow and advancements in digital currency and AI applications [3]. Group 4: Investment Recommendations - The non-bank sector remains underweight, with a total underweight of 3.08 percentage points, suggesting four key investment opportunities: 1) Wealth management opportunities in fintech and brokerage due to resident funds entering the market [4]. 2) Valuation recovery opportunities in the insurance sector as interest rates stabilize [4]. 3) Profit enhancement opportunities for third-party payment companies from the expansion of digital currency scenarios [4]. 4) Broader exit channels for equity investment institutions due to an increase in IPOs in the tech sector [4].

Group 1 - The company conducted a telephone survey with institutional investors on January 22, 2026, discussing key issues such as drug development, subsidiary operations, health product channels, and dividend policies [1] - The company is making steady progress in clinical research for key drug products, including studies on diabetes foot, bone pain, and other areas, which will lay the foundation for expanding application scenarios [2] - The company plans to continue promoting existing product development while selectively extending external projects to complete its product matrix [2] Group 2 - The provincial pharmaceutical company will implement a "double rise and double drop" strategy, focusing on stabilizing existing hospital and distribution market shares while expanding non-drug businesses and new specialty pharmacies to cultivate new growth points [3] - The company aims to enhance operational efficiency by optimizing supply chain management and improving accounts receivable and inventory structures [3] Group 3 - In the health product sector, the company achieved significant breakthroughs in online channels in 2025, with a notable increase in product awareness and sales through strategic partnerships with e-commerce platforms [4] - The company’s toothpaste maintained the top market share in the domestic channel in the first half of 2025, and its anti-hair loss shampoo ranked first on Tmall during the "618" shopping festival [4] Group 4 - The company announced a high dividend policy for 2024, with a total cash dividend of approximately 4.279 billion yuan, representing 90.09% of the net profit attributable to shareholders [5] - For the first half of 2025, the company plans to distribute a cash dividend of 1.818 billion yuan, which is 50.05% of the net profit for that period [5] Group 5 - The strategic layout of the company in drug research, subsidiary operations, channel expansion, and shareholder returns is becoming clearer, with ongoing product development and supply chain optimization expected to strengthen its industry position [6] - The high dividend policy reflects the company's commitment to long-term returns for investors [6]

Group 1 - Yunnan Baiyao announced that on January 22, 2026, it will accept an investor survey conducted by Guotai Junan and other investors, with company representatives participating in the reception and addressing investor inquiries [1] - The company’s securities affairs representative Li Mengjue and investor relations managers Zhang Yu and Yang Kexin will be involved in the investor meeting [1] Group 2 - Local state-owned assets have begun to "bottom-fish" in the auction housing market, purchasing over 60 properties in the Nansha District of Guangzhou at prices around 6,000 to 7,000 yuan per unit, while the average listing price for second-hand homes in the same community exceeds 20,000 yuan [1] - This trend indicates a significant disparity between auction prices and market prices for second-hand homes in the area [1]

Group 1 - Cambridge Technology is a global leader in optical connectivity, broadband, and wireless solutions [1] - The rapid development of AI is expected to lead to an outperformance in the optical module business [1] - The company is actively expanding overseas production capacity and investing in supply chain manufacturers through H-share issuance [1] Group 2 - With a strong background in products, production capacity, North American teams, and supply chain partnerships, the optical module business is poised for further breakthroughs in overseas markets [1] - The average industry valuation suggests a 2026 PE of 32.13x, corresponding to a target price of 161 yuan, with a rating of "Buy" [1]